Bladder Cancer and its Intersection with Pulmonary Hypertension Therapies
The medical community faces a significant challenge in treating pulmonary hypertension (PH). An emerging therapeutic approach involves the drug sildenafil. While it is most commonly associated with erectile dysfunction, its application in PH therapy is gaining momentum. Its role in addressing this complex condition can potentially alter treatment paradigms. Understanding the mechanisms by which sildenafil acts could bring new insights into treatment strategies for PH patients. Sildenafil’s Role in Pulmonary Hypertension Treatment Sildenafil acts as a phosphodiesterase-5